François Malouin

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 7 CIPO patents and 3 EPO patents. Top assignees: Socpra Sciences Et Genie S.e.c., Ulysses Pharmaceutical Products, Inc.. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: François Malouin. Retrieved from https://idiyas.com/inventor/françois-malouin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 66.7

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 21(Granted Patents)

Company Filing History:

11 out of 52

Socpra Sciences Et Genie S.e.c.

patents

1 out of 1

Ulysses Pharmaceutical Products, Inc.

patent

Years Active: 2008-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11324815 - Vaccine constructs and uses thereof againstinfections (2022-05-10),

2. 11129884 - Bacterial vaccine components and uses thereof (2021-09-28),

3. 11065322 - Bacterial vaccine components and uses thereof (2021-07-20),

4. 10716797 - Steroid alkaloids and compositions and kits thereof (2020-07-21),

5. 10576139 - Bacterial vaccine components and uses thereof (2020-03-03),

6. 10137137 - ATP synthase inhibitors and steroid alkaloids and uses thereof as antimicrobial agents and as potentiators for aminoglycosides against pathogenic bacteria (2018-11-27),

7. 10029004 - Bacterial vaccine components and uses thereof (2018-07-24),

8. 9993491 - Guanine riboswitch binding compounds and their use as antibiotics (2018-06-12),

9. 9566322 - Bacterial vaccine components and uses thereof (2017-02-14),

10. 9457033 - Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria (2016-10-04),

11. 8889150 - [object Object] (2014-11-18),

12. 7410974 - Halogenated Quinazolinyl nitrofurans as antibacterial agents (2008-08-12),

Title: The Innovations of Francois Malouin

Introduction

Francois Malouin is a notable inventor based in Eastman, California. He has made significant contributions to the field of bacterial vaccines, holding a total of five patents. His work focuses on the treatment and diagnosis of Staphylococcal intramammary infections, showcasing his dedication to advancing medical science.

Latest Patents

Malouin's latest patents include innovative agents, compositions, methods, and kits that are useful for the treatment and diagnosis of Staphylococcal intramammary infection. These inventions are derived from genes expressed during such infections, specifically genes SACOL0029 and SACOL0442, based on the gene nomenclature from the COL (SACOL) genome. His research aims to provide effective solutions for combating bacterial infections in the medical field.

Career Highlights

Throughout his career, Malouin has worked with various companies, including Socpra—Sciences et Génie, S.E.C. His experience in these organizations has contributed to his expertise in the development of bacterial vaccine components. His work has been instrumental in advancing the understanding and treatment of bacterial infections.

Collaborations

Malouin has collaborated with notable colleagues such as Marianne Allard and Christian Lebeau Jacob. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of bacterial vaccines.

Conclusion

Francois Malouin's contributions to the field of bacterial vaccines are significant and impactful. His innovative patents and collaborations reflect his commitment to improving medical treatments and advancing scientific knowledge. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.